0001410939-22-000092.txt : 20220804 0001410939-22-000092.hdr.sgml : 20220804 20220804160958 ACCESSION NUMBER: 0001410939-22-000092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220802 FILED AS OF DATE: 20220804 DATE AS OF CHANGE: 20220804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simms Christopher Paul CENTRAL INDEX KEY: 0001877012 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 221136611 MAIL ADDRESS: STREET 1: FIVE PENN PLAZA SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: (609) 474-6755 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 wf-form4_165964373903225.xml FORM 4 X0306 4 2022-08-02 0 0001410939 IVERIC bio, Inc. ISEE 0001877012 Simms Christopher Paul C/O IVERIC BIO, INC. 8 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 SVP, Chief Commercial Officer Common Stock 2022-08-02 4 M 0 15000 0 A 22069 D Common Stock 2022-08-02 4 M 0 18750 0 A 40819 D Common Stock 2022-08-03 4 S 0 5454 11.25 D 35365 D Common Stock 2022-08-03 4 S 0 6818 11.25 D 28547 D Restricted Stock Units 2022-08-02 4 M 0 15000 0 D Common Stock 15000.0 0 D Restricted Stock Units 2022-08-02 4 M 0 18750 0 D Common Stock 18750.0 56250 D Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on August 2, 2022. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions ranging from $11.14 to $11.38 per share on August 3, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. Each restricted stock unit represents the contingent right to receive one share of common stock of the Registrant upon vesting of the unit. Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 100% of the shares subject to the award on the first anniversary of the grant date. Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date. /s/ Todd D.C. Anderman, as Attorney-in-Fact for Christopher Simms 2022-08-04